Information Notice No. 80-35, Supplement No. 1: Leaking and Dislodged Iodine-125 Implant Seeds
SSINS No.: 6835 IN 80-35, Supp. 1 UNITED STATES NUCLEAR REGULATORY COMMISSION OFFICE OF INSPECTION AND ENFORCEMENT WASHINGTON, D.C. 20555 October 6, 1982 Information Notice No. 80-35, SUPPLEMENT NO. 1: LEAKING AND DISLODGED IODINE-125 IMPLANT SEEDS Addressees: Medical licensees holding specific licenses for human use of byproduct material in sealed sources. Purpose: This information notice is a supplement to Information Notice No. 80-35, "Leaking and Dislodged Iodine-125 Implant Seeds" (Attachment 1). This information should serve as a reminder for licensees to review the suppliers' guidance accompanying the radioactive sources and the applicators used to implant the sources. No response to this notice is required. Discussion: Since issuance of Information Notice 80-35 on October 10, 1980, the NRC has reviewed reports of five additional incidents involving uptakes of iodine-125 resulting from leaking and dislodged implant seeds. These incidents are described below. 1. Forty iodine-125 seeds were implanted in a patient. The seeds were inserted with difficulty into the plastic tubes used in the implant instrument. There was no apparent difficulty in feeding the sterilized seeds from the plastic tubes into the implant instrument; however, during the process a few seeds were slightly crimped by the forceps causing damage to the seeds. Subsequent surveys detected iodine-125 in the urine and thyroid of the patient. The dose to the thyroid was estimated to be 9 rads. 2. An applicator being used during a prostate implant jammed during the procedure. The physician tried to free the applicator and subsequently ruptured one of the seeds. Subsequent surveys detected iodine-125 only in the physician's thyroid who performed the implant. The dose to the thyroid was estimated to be 120 millirads. 3. The radiation therapy physician felt some resistance while inserting one of the iodine-125 seeds. Rather than force the applicator being used to perform the prostate implant, the physician pulled back on the inserting rod of the applicator a second time and then continued to insert the seed without further difficulty. Subsequent surveys detected iodine-125 in the urine and thyroid of the patient. The dose to the thyroid was estimated to be 22 rads. 8208190233 . IN 80-35, Supp. 1 October 6, 1982 Page 2 of 2 4. Iodine-125 was detected in the urine and thyroid of a patient during surveys performed following implantation of iodine-125 seeds for inter- stitial treatment of cancer of the prostate. Faulty (leaking) seeds were determined to be the cause of the iodine-125 uptake. The dose to the thyroid was estimated to be 10 rads. 5. Iodine-125 was detected in the urine and thyroid of two patients during surveys following transurethral resection procedures. In both cases, the use of electronic cauterization was determined to be the cause for the loss of integrity of the seeds. The dose to the thyroid in this incident was estimated to be 6.5 and 0.44 rads respectively. No written response to this information notice is required. If you need additional information regarding this subject, contact the Administrator of the appropriate NRC Regional Office. L. I. Cobb, Director, Division of Fuel Facilities, Materials and Safeguards Office of Inspection and Enforcement Attachments: 1. Information Notice No. 80-35 2. List of Recently Issued Information Notices CONTACT: H. Karagiannis 301-492-9655
Page Last Reviewed/Updated Tuesday, March 09, 2021
Page Last Reviewed/Updated Tuesday, March 09, 2021